First Trust Advisors LP Gilead Sciences, Inc. Transaction History

First Trust Advisors LP

  • $108 Billion
  • Q1 2025

A detailed history of First Trust Advisors LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 2,726,844 shares of GILD stock, worth $296 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
2,726,844
Previous 2,962,221 7.95%
Holding current value
$296 Million
Previous $274 Million 11.67%
% of portfolio
0.28%
Previous 0.25%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$89.14 - $117.41 $21 Million - $27.6 Million
-235,377 Reduced 7.95%
2,726,844 $306 Million
Q4 2024

Feb 13, 2025
BUY
$83.95 - $97.9 $4.07 Million - $4.74 Million
48,442 Added 1.66%
2,962,221 $274 Million
Q3 2024

Nov 13, 2024
SELL
$66.59 - $83.99 $71.7 Million - $90.5 Million
-1,077,079 Reduced 26.99%
2,913,779 $244 Million
Q2 2024

Aug 13, 2024
SELL
$63.15 - $72.88 $12.1 Million - $14 Million
-192,379 Reduced 4.6%
3,990,858 $274 Million
Q1 2024

May 13, 2024
BUY
$71.58 - $87.29 $4.69 Million - $5.72 Million
65,509 Added 1.59%
4,183,237 $306 Million
Q4 2023

Feb 13, 2024
SELL
$73.27 - $83.09 $28 Million - $31.7 Million
-381,573 Reduced 8.48%
4,117,728 $334 Million
Q3 2023

Nov 13, 2023
BUY
$73.94 - $80.67 $33.6 Million - $36.6 Million
454,229 Added 11.23%
4,499,301 $337 Million
Q2 2023

Aug 14, 2023
SELL
$76.01 - $86.7 $139 Million - $158 Million
-1,824,781 Reduced 31.09%
4,045,072 $312 Million
Q1 2023

May 15, 2023
BUY
$77.31 - $88.08 $181 Million - $206 Million
2,339,008 Added 66.24%
5,869,853 $487 Million
Q4 2022

Feb 09, 2023
SELL
$62.32 - $89.47 $22.8 Million - $32.8 Million
-366,347 Reduced 9.4%
3,530,845 $303 Million
Q3 2022

Nov 14, 2022
SELL
$59.54 - $68.01 $34.2 Million - $39.1 Million
-574,230 Reduced 12.84%
3,897,192 $240 Million
Q2 2022

Aug 12, 2022
SELL
$57.72 - $65.01 $95.5 Million - $108 Million
-1,655,263 Reduced 27.02%
4,471,422 $276 Million
Q1 2022

May 13, 2022
BUY
$57.92 - $72.58 $180 Million - $226 Million
3,114,535 Added 103.4%
6,126,685 $364 Million
Q4 2021

Feb 08, 2022
BUY
$64.88 - $73.64 $26.6 Million - $30.2 Million
409,793 Added 15.75%
3,012,150 $219 Million
Q3 2021

Nov 15, 2021
SELL
$67.69 - $73.03 $15.4 Million - $16.6 Million
-226,890 Reduced 8.02%
2,602,357 $182 Million
Q2 2021

Aug 16, 2021
BUY
$63.47 - $69.35 $34 Million - $37.2 Million
536,113 Added 23.38%
2,829,247 $195 Million
Q1 2021

May 14, 2021
BUY
$60.0 - $68.46 $1.86 Million - $2.12 Million
31,017 Added 1.37%
2,293,134 $148 Million
Q4 2020

Feb 02, 2021
SELL
$56.65 - $64.55 $76.8 Million - $87.5 Million
-1,355,696 Reduced 37.47%
2,262,117 $132 Million
Q3 2020

Nov 05, 2020
BUY
$62.1 - $78.08 $23.6 Million - $29.7 Million
380,737 Added 11.76%
3,617,813 $229 Million
Q2 2020

Jul 22, 2020
BUY
$72.34 - $84.0 $123 Million - $143 Million
1,701,510 Added 110.81%
3,237,076 $249 Million
Q1 2020

May 06, 2020
SELL
$62.63 - $80.22 $3.05 Million - $3.9 Million
-48,629 Reduced 3.07%
1,535,566 $115 Million
Q4 2019

Feb 03, 2020
SELL
$61.62 - $67.78 $54.2 Million - $59.6 Million
-879,585 Reduced 35.7%
1,584,195 $103 Million
Q3 2019

Nov 04, 2019
SELL
$62.51 - $69.0 $22.6 Million - $25 Million
-361,927 Reduced 12.81%
2,463,780 $156 Million
Q2 2019

Jul 30, 2019
BUY
$61.87 - $69.38 $76.5 Million - $85.8 Million
1,236,379 Added 77.79%
2,825,707 $191 Million
Q1 2019

May 09, 2019
BUY
$62.53 - $70.05 $16 Million - $17.9 Million
255,863 Added 19.19%
1,589,328 $103 Million
Q4 2018

Feb 07, 2019
SELL
$60.54 - $79.0 $3.75 Million - $4.89 Million
-61,874 Reduced 4.43%
1,333,465 $83.4 Million
Q3 2018

Oct 25, 2018
BUY
$71.28 - $78.92 $29.6 Million - $32.8 Million
415,500 Added 42.4%
1,395,339 $108 Million
Q2 2018

Aug 02, 2018
SELL
$64.88 - $75.68 $19.6 Million - $22.8 Million
-301,694 Reduced 23.54%
979,839 $69.4 Million
Q1 2018

Apr 23, 2018
BUY
$72.84 - $88.8 $12.5 Million - $15.2 Million
171,189 Added 15.42%
1,281,533 $96.6 Million
Q4 2017

Feb 08, 2018
SELL
$71.15 - $83.52 $5.64 Million - $6.62 Million
-79,304 Reduced 6.67%
1,110,344 $79.5 Million
Q3 2017

Oct 24, 2017
BUY
$72.11 - $85.47 $85.8 Million - $102 Million
1,189,648
1,189,648 $96.4 Million

Others Institutions Holding GILD

# of Institutions
2,288
Shares Held
997M
Call Options Held
9.62M
Put Options Held
10M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $136B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email